Advanced in Age-Related Macular Degeneration (ARMD)

Wilson J. Heriot

Melbourne, VIC, AU 
Advanced in Age-Related Macular Degeneration (ARMD)
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Wilson Heriot practices in Melbourne, Australia. Mr. Heriot is rated as an Advanced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, Cerebral Hypoxia, and Vitrectomy.

His clinical research consists of co-authoring 18 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles and participated in 2 clinical trials in the study of Age-Related Macular Degeneration (ARMD).

Gender
Male

Locations

Melbourne, VIC, Australia
Other Locations
Glen Iris, VIC, Australia
Parkville, NSW, Australia
VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study To Evaluate The Safety and Tolerability of EXN407 in Subjects With Centre Involved Diabetic Macular Oedema Secondary to Diabetes Mellitus
A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study To Evaluate The Safety and Tolerability of EXN407 in Subjects With Centre Involved Diabetic Macular Oedema Secondary to Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 09, 2025
Intervention Type: Drug
Study Drug: EXN407
Study Phase: Phase 1/Phase 2
Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging
Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging
Enrollment Status: Terminated
Publish Date: February 05, 2019
Intervention Type: Device
View 1 Less Clinical Trial

18 Total Publications

Postoperative Outcomes of Combined Phacovitrectomy for Epiretinal Membrane With a Concurrent Cataract vs Standalone Phacoemulsification for a Cataract.
Postoperative Outcomes of Combined Phacovitrectomy for Epiretinal Membrane With a Concurrent Cataract vs Standalone Phacoemulsification for a Cataract.
Journal: Journal of vitreoretinal diseases
Published: January 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Heriot's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile